iOrganBio
Chapel Hill
About iOrganBio
iOrganBio is a pioneering cell production platform that uses CellForge to facilitate the intelligent manufacturing of human cells and organoids.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Oct 2025)
- Website: iorgan.bio
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/iorganbio-36241 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.